Logo image of FLYE

FLY-E GROUP INC (FLYE) Stock Fundamental Analysis

NASDAQ:FLYE - Nasdaq - US3439271095 - Common Stock - Currency: USD

0.4857  +0.05 (+10.39%)

After market: 0.4999 +0.01 (+2.92%)

Fundamental Rating

2

Overall FLYE gets a fundamental rating of 2 out of 10. We evaluated FLYE against 39 industry peers in the Automobiles industry. FLYE has a bad profitability rating. Also its financial health evaluation is rather negative. FLYE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year FLYE has reported negative net income.
In the past year FLYE has reported a negative cash flow from operations.
FLYE Yearly Net Income VS EBIT VS OCF VS FCFFLYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M 2M 3M 4M

1.2 Ratios

FLYE's Return On Assets of -3.54% is fine compared to the rest of the industry. FLYE outperforms 64.10% of its industry peers.
FLYE has a better Return On Equity (-10.05%) than 64.10% of its industry peers.
Industry RankSector Rank
ROA -3.54%
ROE -10.05%
ROIC N/A
ROA(3y)5.77%
ROA(5y)N/A
ROE(3y)39.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FLYE Yearly ROA, ROE, ROICFLYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Gross Margin of FLYE (42.79%) is better than 94.87% of its industry peers.
FLYE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FLYE Yearly Profit, Operating, Gross MarginsFLYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

FLYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FLYE has less shares outstanding
The debt/assets ratio for FLYE has been reduced compared to a year ago.
FLYE Yearly Shares OutstandingFLYE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
FLYE Yearly Total Debt VS Total AssetsFLYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

FLYE has an Altman-Z score of 1.15. This is a bad value and indicates that FLYE is not financially healthy and even has some risk of bankruptcy.
FLYE has a better Altman-Z score (1.15) than 61.54% of its industry peers.
FLYE has a Debt/Equity ratio of 0.53. This is a neutral value indicating FLYE is somewhat dependend on debt financing.
FLYE has a Debt to Equity ratio of 0.53. This is in the better half of the industry: FLYE outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC15.17%
FLYE Yearly LT Debt VS Equity VS FCFFLYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

FLYE has a Current Ratio of 1.30. This is a normal value and indicates that FLYE is financially healthy and should not expect problems in meeting its short term obligations.
FLYE has a Current ratio (1.30) which is comparable to the rest of the industry.
A Quick Ratio of 0.43 indicates that FLYE may have some problems paying its short term obligations.
The Quick ratio of FLYE (0.43) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.43
FLYE Yearly Current Assets VS Current LiabilitesFLYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

1

3. Growth

3.1 Past

FLYE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.93%, which is quite impressive.
FLYE shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.90%.
EPS 1Y (TTM)39.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3575%
Revenue 1Y (TTM)47.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLYE Yearly Revenue VS EstimatesFLYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

FLYE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLYE Price Earnings VS Forward Price EarningsFLYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLYE Per share dataFLYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FLYE!.
Industry RankSector Rank
Dividend Yield N/A

FLY-E GROUP INC

NASDAQ:FLYE (5/30/2025, 8:00:00 PM)

After market: 0.4999 +0.01 (+2.92%)

0.4857

+0.05 (+10.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.15%
Inst Owner Change146.29%
Ins Owners68.45%
Ins Owner Change0%
Market Cap11.94M
AnalystsN/A
Price TargetN/A
Short Float %4.42%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 0.91
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS1.16
BVpS0.53
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -10.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.79%
FCFM N/A
ROA(3y)5.77%
ROA(5y)N/A
ROE(3y)39.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1316.7%
Cap/Sales 18.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.43
Altman-Z 1.15
F-Score1
WACC15.17%
ROIC/WACCN/A
Cap/Depr(3y)581.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.43%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3575%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y145.23%
OCF growth 3YN/A
OCF growth 5YN/A